Pharmaceuticals

Growing Demand For Critical Care Antiarrhythmic Drugs Amid Rising Cardiovascular Disease Prevalence Is Contributing To Changes In The Pentavalent Market

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Pentavalent Market Between 2026 And 2030?

The pentavalent market has experienced consistent expansion in recent years. It is projected to increase from $2.7 billion in 2025 to $2.83 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.6%. The historical growth of this market is attributable to rising infant mortality rates, restricted access to vaccines, the prevalence of rotavirus infections, government vaccination initiatives, and global public health campaigns.

The pentavalent market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $3.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth during the forecast period include innovations in vaccine formulation technology, a rise in healthcare spending, the broadening of immunization initiatives in developing nations, collaborations among pharmaceutical firms, and the adoption of digital tracking systems for vaccine coverage. Key trends observed within the forecast timeframe encompass an increase in infant immunization efforts, governmental investment in vaccine development, the expansion of public health infrastructure, heightened awareness regarding rotavirus prevention, and the development of cold chain logistics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Which Key Drivers Are Affecting The Pentavalent Market Development?

The increasing incidence of diphtheria is projected to stimulate the growth of the pentavalent market. Diphtheria, caused by the bacterium Corynebacterium diphtheriae, is a severe and highly contagious illness characterized by significant difficulties in eating and breathing, alongside the potential for skin ulcers. The pentavalent vaccine offers protection to children against Diphtheria through a 3-dose immunization schedule, consequently leading to an elevated demand for these vaccines as the prevalence of diphtheria rises. For instance, in July 2025, the European Centre for Disease Prevention and Control, a Europe-based government agency, reported a total of 126 laboratory-confirmed cases of C. diphtheriae ST574 across Germany, with 55 cases in 2022, 49 in 2023, 18 in 2024, and at least 4 cases in 2025. This demonstrates how the growing occurrence of diphtheria is actively driving the expansion of the pentavalent market.

Pentavalent Market Driver: Increasing Healthcare Expenditure To Propel Pentavalent Market Growth

How Is The Pentavalent Market Organized By Segment Classification?

The pentavalent market covered in this report is segmented –

1) By Type: Pentavalent Vaccines (DTP-HepB-Hib combination), Other Combination Vaccines

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Pentavalent Vaccines (DTP-HepB-Hib combination): DTP-HepB-Hib (Whole Cell), DTP-HepB-Hib (Acellular)

2) By Other Combination Vaccines: Hexavalent Vaccines

Which Trends Are Influencing Demand In The Pentavalent Market?

Key companies operating within the pentavalent market are concentrating on developing innovative solutions, such as pentavalent immunization vaccines. These pentavalent immunization vaccines are a form of combination vaccine engineered to provide protection against five distinct diseases. For example, in October 2023, Pfizer, a US-based pharmaceutical company, announced the FDA approval for its ‘Penbraya’ pentavalent vaccine. It stands as the initial and sole pentavalent vaccine offering defense against the five most prevalent meningococcal serogroups, namely A, B, C, W-135, and Y, in individuals aged 10 through 25 years. The vaccine incorporates elements from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. Penbraya has been determined to be effective in providing protection against the five meningococcal serogroups responsible for the majority of global cases of invasive meningococcal disease.

Who Are The Industry Participants Involved In The Pentavalent Market?

Major companies operating in the pentavalent market are Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Get The Full Pentavalent Market Report:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Which Region Dominates The Pentavalent Market By Market Share?

Asia-Pacific was the largest region in the pentavalent market in 2025. The regions covered in the pentavalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pentavalent Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Browse Through More Reports Similar to the Global Pentavalent Market 2026, By The Business Research Company

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795